Rettenmaier M A, Miller R D, Berman M L, DiSaia P J
Am J Obstet Gynecol. 1984 Dec 1;150(7):882-4. doi: 10.1016/0002-9378(84)90467-8.
Moxalactam was administered prior to operation to patients undergoing operation for a known or suspected gynecologic malignancy. Subsequent plasma and tissue levels demonstrated a prolonged duration of action and rapid concentration in pelvic organs after infusion.
对于已知或疑似患有妇科恶性肿瘤而接受手术的患者，在手术前给予其拉氧头孢。随后的血浆和组织水平显示，输注后其作用持续时间延长，且在盆腔器官中的浓度迅速升高。
